$吉利德科学(GILD)$更多有关瑞德西韦的供应细节： .More than 140,000 treatment courses by the end of May 2020
More than 500,000 treatment courses by October 2020
More than 1 million treatment courses by December 2020
Several million treatment courses in 2021, if required
吉利德还会推出鼻子吸入和片剂的瑞德西韦。(这个也是第一次披露） Our researchers are also looking at the future potential for developing inhaled and potentially oral dosage forms of remdesivir to help alleviate the need for hospital administration of the drug.